Maharashtra FDA presses Vimal Elaichi celebrity endorsers over alleged surrogate pan masala ads

Ajay Devgn and Tiger Shroff have responded to Maharashtra FDA show-cause notices tied to Vimal Elaichi advertising, which regulators suspect may promote prohibited Vimal Pan Masala by proxy. Shah Rukh Khan’s response is pending, according to reports.

— Source publishedFri, 4 Sept, 2026, 14:08 IST·First seen Fri, 4 Sept, 2026, 14:30 IST·Source Business Today · Latest

What happened

Maharashtra FDA received responses from Ajay Devgn and Tiger Shroff to notices over Vimal Elaichi advertising, which it suspects may surrogate-promote

Key facts

  • 3 actors served show-cause notices
  • Pan masala prohibited in Maharashtra for 1 year
  • Prohibition order dated July 13, 2026

Why this matters

Any partnership, investment or acquisition involving pan-masala-adjacent brands should price in state-level advertising restrictions, endorsement liabilities and the durability of brand-extension-led demand generation.

What to watch

  • Maharashtra FDA's final finding, penalty, product-sale restriction, or referral to another enforcement body.
  • Shah Rukh Khan's response and whether it differs materially from the responses of Ajay Devgn and Tiger Shroff.
  • Evidence cited by regulators on shared trademarks, packaging similarity, retail availability, pricing, or consumer confusion between Vimal Elaichi and Vimal Pan Masala.
  • Any order requiring campaign takedowns, altered creative, disclaimer standards, or restrictions on celebrity appearances.
  • Follow-on notices from other state food-safety regulators, the Central Consumer Protection Authority, ASCI, or court petitions.
  • Changes in Vimal's Maharashtra advertising mix, celebrity contracts, or retailer-facing product positioning.
  • Vimal is likely to submit product-separation, packaging, sales-distribution, and advertising-compliance evidence to distinguish elaichi from pan masala.
  • Celebrity representatives are likely to emphasize contractual reliance on advertiser assurances and may seek public clarification or legal closure.
  • The brand may reduce celebrity-led creative in Maharashtra, shift spend to lower-risk product messaging, or add more explicit elaichi-focused disclosures.
  • Competing FMCG and tobacco-adjacent brands may review surrogate-brand architecture, endorsement clauses, and state-specific media plans.
  • Media owners, digital platforms, and outdoor advertising vendors may seek written advertiser certifications before accepting similar campaigns.